Table of Contents Author Guidelines Submit a Manuscript
Research Letters in Biochemistry
Volume 2008, Article ID 801849, 5 pages
http://dx.doi.org/10.1155/2008/801849
Research Letter

Liver X Receptor Agonists Inhibit the Phospholipid Regulatory Gene CTP: Phosphoethanolamine Cytidylyltransferase-Pcyt2

Department of Human Health and Nutritional Sciences, University of Guelph, Ontario, N1G 2W1, Canada

Received 27 February 2008; Accepted 7 April 2008

Academic Editor: David Brindley

Copyright © 2008 Lin Zhu and Marica Bakovic. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. P. Kennedy and S. B. Weiss, “The function of cytidine coenzymes in the biosynthesis of phospholipides,” Journal of Biological Chemistry, vol. 222, no. 1, pp. 193–214, 1956. View at Google Scholar
  2. M. Bakovic, M. D. Fullerton, and V. Michel, “Metabolic and molecular aspects of ethanolamine phospholipid biosynthesis: the role of CTP: phosphoethanolamine cytidylyltransferase (Pcyt2),” Biochemistry and Cell Biology, vol. 85, no. 3, pp. 283–300, 2007. View at Publisher · View at Google Scholar · View at PubMed
  3. R. Geyeregger, M. Zeyda, and T. M. Stulnig, “Liver X receptors in cardiovascular and metabolic disease,” Cellular and Molecular Life Sciences, vol. 63, no. 5, pp. 524–539, 2006. View at Publisher · View at Google Scholar · View at PubMed
  4. S. B. Joseph, A. Castrillo, B. A. Laffitte, D. J. Mangelsdorf, and P. Tontonoz, “Reciprocal regulation of inflammation and lipid metabolism by liver X receptors,” Nature Medicine, vol. 9, no. 2, pp. 213–219, 2003. View at Publisher · View at Google Scholar · View at PubMed
  5. C. M. Johnson, Z. Yuan, and M. Bakovic, “Characterization of transcription factors and cis-acting elements that regulate human CTP: phosphoethanolamine cytidylyltransferase (Pcyt2),” Biochimica et Biophysica Acta, vol. 1735, no. 3, pp. 230–235, 2005. View at Publisher · View at Google Scholar · View at PubMed
  6. M. D. Fullerton, F. Hakimuddin, and M. Bakovic, “Developmental and metabolic effects of disruption of the mouse CTP: phosphoethanolamine cytidylyltransferase gene (Pcyt2),” Molecular and Cellular Biology, vol. 27, no. 9, pp. 3327–3336, 2007. View at Publisher · View at Google Scholar · View at PubMed
  7. A. Poloumienko, A. Coté, A. T. T. Quee, L. Zhu, and M. Bakovic, “Genomic organization and differential splicing of the mouse and human Pcyt2 genes,” Gene, vol. 325, pp. 145–155, 2004. View at Publisher · View at Google Scholar
  8. A. Tie and M. Bakovic, “Alternative splicing of CTP: phosphoethanolamine cytidylyltransferase produces two isoforms that differ in catalytic properties,” Journal of Lipid Research, vol. 48, no. 10, pp. 2172–2181, 2007. View at Publisher · View at Google Scholar · View at PubMed
  9. M. Agassandian, J. Zhou, L. A. Tephly, A. J. Ryan, A. B. Carter, and R. K. Mallampalli, “Oxysterols inhibit phosphatidylcholine synthesis via ERK docking and phosphorylation of CTP: phosphocholine cytidylyltransferase,” Journal of Biological Chemistry, vol. 280, no. 22, pp. 21577–21587, 2005. View at Publisher · View at Google Scholar · View at PubMed
  10. P. G. Yancey, M.-A. Kawashiri, R. Moore et al., “In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux,” Journal of Lipid Research, vol. 45, no. 2, pp. 337–346, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. Y. Ninomiya, T. Yasuda, M. Kawamoto, O. Yuge, and Y. Okazaki, “Liver X receptor ligands inhibit the lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 and diminish prostaglandin E2 production in murine peritoneal macrophages,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 1, pp. 44–50, 2007. View at Publisher · View at Google Scholar · View at PubMed
  12. D. A. Ford and R. W. Gross, “Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 10, pp. 3479–3483, 1989. View at Publisher · View at Google Scholar
  13. H. Morita, K. Nakanishi, T. Dohi, E. Yasugi, and M. Oshima, “Phospholipid turnover in the inflamed intestinal mucosa: arachidonic acid-rich phosphatidyl/plasmenyl-ethanolamine in the mucosa in inflammatory bowel disease,” Journal of Gastroenterology, vol. 34, no. 1, pp. 46–53, 1999. View at Publisher · View at Google Scholar
  14. D. Ogawa, J. F. Stone, Y. Takata et al., “Liver X receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways,” Circulation Research, vol. 96, no. 7, pp. e59–e67, 2005. View at Publisher · View at Google Scholar · View at PubMed
  15. Y. Liu, C. Yan, Y. Wang et al., “Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice,” Endocrinology, vol. 147, no. 11, pp. 5061–5068, 2006. View at Publisher · View at Google Scholar · View at PubMed